Navigation Links
PharmAthene Reports Year-End 2012 Financial And Operational Results
Date:3/13/2013

>

19,795,84519,613,006Property and equipment, net

483,976788,666Other long-term assets and deferred costs

113,13053,384Goodwill

2,348,4532,348,453Total assets

$   22,741,404$   22,803,509LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
,697,280$
,445,700Accrued expenses and other liabilities

2,328,8772,655,330Deferred revenue

1,381,755514,312Current portion of long-term debt

749,997-Short-term debt

1,330,507-Total current liabilities

7,488,4164,615,342Other long-term liabilities

579,427449,709Long-term debt, less current portion

1,704,108-Derivative instruments

1,295,6131,886,652Total liabilities

11,067,5646,951,703Stockholders' equity:Common stock, $0.0001 par value; 100,000,000 shares authorized; 48,352,651 and 48,236,172 shares issued and outstanding at December 31, 2012 and 2011, respectively

4,8354,824Additional paid-in-capital

210,495,905208,525,917Accumulated other comprehensive (loss) income

(217,328)1,010,522Accumulated deficit

(198,609,572)(193,689,457)Total stockholders' equity

11,673,84015,851,806Total liabilities and stockholders' equity

$  22,741,404$  22,803,509 PHARMATHENE, INC.CONSOLIDATED STATEMENTS OF OPERATIONSYear Ended December 31,20122011Revenue

$ 25,175,887$  24,266,274Operating expenses:Research and development

19,509,62921,219,853General and administrative

11,628,73214,311,079Depreciation and amortization

303,916461,073Total operating expenses

31,442,27735,992,005Loss from operations

$ (6,266,390)$ (11,725,731)Other income (expense):Interest income

17,80816,660Interest expense

(342,561)(54,573)Gain on the sale of assets held for sale

-781,760Realization of cumulative translation adjustment 

1,227,656-Chan
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
2. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
3. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
4. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
5. PharmAthene Reports First Quarter 2012 Financial Results
6. PharmAthene Reports Third Quarter 2012 Financial Results
7. PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013
8. PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013
9. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
10. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
11. Interleukin Genetics Reports Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015 Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics including high value and ... first quarter 2015 financial results will be released ... of market. At 8:30 am Eastern Time, Pfenex management ... financial results and provide a business update. A press ...
(Date:5/1/2015)... Albany Molecular Research Inc. (NASDAQ: AMRI ... AMRI,s President and Chief Executive Officer, will present at ... Conference on Wednesday, May 13, 2015 at 4:20 p.m. ... presentation can be accessed at AMRI,s Investor Relations web ... will be archived for 90 days following the live ...
(Date:4/30/2015)... N.J. , April 30, 2015  Roka Bioscience, ... focused on providing advanced testing solutions for the detection ... results for the first quarter of 2015 on May ... Roka Bioscience will also host a conference ... 2015 to discuss its first quarter financial results. During ...
(Date:4/30/2015)... Nitto Avecia, a leading biotechnology manufacturer and ... production capability to serve biotechnology pharmaceutical clients. A ... continues to drive Nitto Avecia to enhance synthesis ... , In Fall 2014, Nitto Avecia first ... its Milford, MA facility, which is recognized as ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... ANGELES, May 22 A new prize has ... the study of how,influences from outside the cell ... honors a researcher or physician who has used ... in medical,understanding. The inaugural recipient is Randy Jirtle, ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), a ... novel drugs in the,therapeutic areas of infection, cancer and ... founding member of the new NASDAQ OMX,AeA Illinois Tech ... May 19. The,only existing statewide public technology index in ...
... CT ... Contrast Injections, WARRENDALE, ... Extravasation Detector has received a 2008 Medical Design,Excellence Award(R) (MDEA). ... leaking intravenous contrast media from the injection site,into surrounding tissue ...
Cached Biology Technology:Genetic Breakthroughs Honored With New Scientific Award 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 2Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 3Advanced Life Sciences Selected as Founding Member of the New NASDAQ OMX AeA Illinois Tech Index 4MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award 2MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award 3
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... New research published by a Queen,s University Belfast academic has ... retain a memory of it. The study, which looked ... was carried out by Professor Bob Elwood and Mirjam Appel ... been published in the journal Animal Behaviour . ...
... first time, MIT engineers and colleagues have observed the initiation ... millions of animals in this case, fish. The ... to the conservation of marine ecosystems that vast oceanic fish ... of Science . It also confirms theories about ...
... obtained the first glimpse of a protein that keeps certain ... P-glycoprotein or P-gp for short, is one of the main ... structure may help scientists design more effective drugs. The ... of the journal Science . "This structure ...
Cached Biology News:Crabs' memory of pain confirmed by Queen's academic 2Team IDs genesis of mass migrations 2Team IDs genesis of mass migrations 3Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 3
... Create 100% capped transcripts with the ... higher yields of 100% capped (versus 40% ... mRNA messages in about 2 hours. mScript™ ... has been shown to be up to ...
Porcine parvovirus and mycoplasma tested. Contains 0.5 g/L of trypsin (1:250) and 0.2 g/L of EDTA4Na in Hanks' Balanced Salt Solution without CaCl2 MgCl2 6H2O and MgSO4 7H2O. Contains phenol red....
...
...
Biology Products: